| |
| |
|
| Insider
Information: |
Sanders Charles A |
| Relationship: |
Director |
| City: |
Chapel Hill |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
90,020 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,284,801 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,020 |
|
|
| Total
Value |
$11,284,801 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 17.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biopure Corp |
BPURQ |
Director |
2005-08-30 |
25,663 |
2003-08-06 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2009-05-18 |
26,383 |
2003-11-12 |
0 |
Premium* |
|
|
Icagen Inc |
ICGN |
Director |
2011-09-02 |
0 |
|
0 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
Director |
2011-08-10 |
15,159 |
|
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2016-02-29 |
12,971 |
2010-02-08 |
0 |
Premium* |
|
|
Liposcience Inc |
LPDX |
Director |
2013-01-30 |
9,844 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2016-02-29 |
4 |
A |
$1.99 |
$8,748 |
D/D |
4,396 |
12,971 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2015-11-30 |
4 |
A |
$10.61 |
$8,743 |
D/D |
824 |
8,575 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2015-08-31 |
4 |
A |
$11.64 |
$8,742 |
D/D |
751 |
7,751 |
0 |
- |
|
| LPDX |
Liposcience Inc |
Director |
– • – |
2013-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,114 |
9,844 |
0 |
- |
|
| LPDX |
Liposcience Inc |
Director |
– • – |
2013-01-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,730 |
|
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
– • – |
2012-03-13 |
4 |
B |
$5.22 |
$10,430 |
D/D |
2,000 |
7,000 |
2.39 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-09-02 |
4 |
D |
$6.00 |
$153,942 |
D/D |
(25,657) |
0 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-09-01 |
4 |
OE |
$2.56 |
$38,140 |
D/D |
11,500 |
25,657 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2011-08-10 |
4 |
B |
$1.16 |
$11,600 |
D/D |
10,000 |
15,159 |
2.39 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2010-05-11 |
4 |
B |
$5.59 |
$27,950 |
D/D |
5,000 |
5,159 |
2.39 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
– • – |
2010-02-08 |
4 |
B |
$6.66 |
$33,300 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2010-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,724 |
113,261 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2009-12-17 |
4 |
OE |
$0.50 |
$1,198 |
D/D |
2,396 |
83,537 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2009-05-18 |
4 |
AS |
$28.44 |
$94,791 |
D/D |
(3,333) |
26,383 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2009-05-18 |
4 |
OE |
$10.05 |
$33,497 |
D/D |
3,333 |
29,716 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2009-05-11 |
4 |
OE |
$10.05 |
$33,497 |
D/D |
3,333 |
29,716 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2009-05-11 |
4 |
AS |
$30.41 |
$101,357 |
D/D |
(3,333) |
26,383 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2009-05-04 |
4 |
OE |
$10.05 |
$33,507 |
D/D |
3,334 |
29,717 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2009-05-04 |
4 |
AS |
$30.08 |
$100,287 |
D/D |
(3,334) |
26,383 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2009-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
29,787 |
81,141 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2008-05-27 |
4 |
AS |
$26.40 |
$89,128 |
D/D |
(3,333) |
26,383 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2008-05-27 |
4 |
OE |
$14.20 |
$47,329 |
D/D |
3,333 |
29,716 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2008-05-20 |
4 |
AS |
$27.46 |
$92,001 |
D/D |
(3,333) |
26,383 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2008-05-20 |
4 |
OE |
$14.20 |
$47,329 |
D/D |
3,333 |
29,716 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2008-05-13 |
4 |
OE |
$14.20 |
$47,343 |
D/D |
3,334 |
29,717 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
